Lower Body Parkinsonism Patients: Increased Blood Flow in Posterior Cerebral Arteries

Research Article

Austin J Neurol Disord Epilepsy. 2014;1(2): 1008.

Lower Body Parkinsonism Patients: Increased Blood Flow in Posterior Cerebral Arteries

Salazar G*, Fragoso M and Rey A

Department of Neurology, Hospital CST. Terrassa, Spain

*Corresponding author: Gabriel Salazar, Department of Neurology, Hospital CST. Terrassa, Barcelona, Spain

Received: December 03, 2014; Accepted: January 06, 2015; Published: January 08, 2015

Abstract

Introduction: Lower Body Parkinsonism (LBP) is a bilateral, symmetric lower limbs Parkinsonism without a resting tremor, a poor L-dopa response and with a minimal upper limbs involvement. Patients usually demonstrate gait difficulties due to freezing gait and falls, causing a major grade of disability when compared to idiopathic Parkinson's Disease patients (PD). Small vessel disease has been related to the pathophysiology of this type of secondary Parkinsonism. We decided to study the hemodynamic characteristics of the cerebral arteries of patients affected with LBP and compare them to PD patients using a Transcranial Doppler.

Patients and Methods: We enrolled 12 LBP, 15 PD patients and 15 agematched healthy control subjects. A Transcranial Doppler was performed on patients and subjects in order to determine the systolic and diastolic velocities and pulsatility index (PI) in the anterior and posterior circuit cerebral arteries.

Results: The LBP patients consisted of 7 men and 5 females; mean age 74 years; Hoenh and Yarh stages 2 and 3. PD patients consisted of 9 males and 6 females; mean age 70 years; Hoehn and yahr stages 2 and 3. LBP patients showed a mean systolic velocity of 193 cm/s, diastolic velocity 64cm/s and PI 2.22 (p: 0.01) in the Posterior Cerebral Arteries (PCA), The remaining cerebral arteries showed normal velocities and PI in LBP and PD patients as well as in normal subjects.

Conclusion: The LBP patients of this study showed a statistically significant difference in the mean systolic velocity and PI of the PCA compared to PD patients and normal subjects.

Keywords: Transcranial doppler; Lower body parkinsonism; Vascular parkinsonism

Introduction

Parkinsonism due to cerebrovascular disease or Vascular Parkinsonism (VP) is a heterogeneous clinical entity representing 4-12% of all cases of Parkinsonism [1]. Lower Body Parkinsonism (LBP) is a recognized clinical expression of VP and is characterized by rigidity and bradykinesia, mainly affecting the lower limbs. Patients with LBP demonstrate a great difficulty for walking; postural instability and falls are the most remarkable clinical symptoms [2,3]. According to some authors, patients with the clinical criteria of LBP show a poor response to L-dopa therapy and resting tremor is an uncommon finding [4,5]. LBP is considered for some authors as a variety of vascular Parkinsonism, with other clinical presentations of VP found in the medical literature [6,7]. The etiology of LBP is unknown, but it has been classically related to vascular risk factors for stroke [8, 9]. As with other secondary Parkinsonism, the diagnosis is based on clinical criteria and few paraclinical tools are useful nowadays to confirm LBP. For the time being, there are no biomarkers for LBP, neither electrophysiological nor radiological biomarkers for LBP have been reported in the medical literature [10,11]. In view of the high incidence of vascular risk factors for stroke in LBP patients, we designed a clinical-sonographic study to determine the hemodynamic characteristics of the intracranial arteries of patients with LBP.

Patients and Methods

We defined LBP as a lower body Parkinsonism (rigidity and bradykinesia in the lower limbs) disproportionate in relation to the upper limbs and an L-dopa test improvement of less than 30% in the Part III of the UPDRS scale.

12 patients with the clinical criteria of LBP, 15 Parkinson's Disease (PD) patients and 15 aged matched-non ill subjects with similar demographic characteristics were enrolled. Other secondary causes of Parkinsonism were ruled out. Patients with a clinical history of ischemic stroke were excluded.

The clinical evaluation consisted in total UPDRS, Hoen and Yahr stages and Swab and England Scales. Determination of Vascular risk factors for stroke was asked systematically to patients and subjects. A cranial angio-MRI was performed in all the patients, focusing on the brainstem.

A continuous Transcranial Doppler with a 2Hz transducer was performed on the LBP, PD patients and on normal subjects. PD and LBD patients were under l-dopa effects when the Transcranial Doppler was performed. The mean time duration between the l-dopa intake and the Transcranial Doppler was 2 ± 0.5 hours.

Transtemporal and sub-occipital acoustic windows were used to evaluate the anterior and posterior brain vascular circuit (bilateral) and posterior circuit. Systolic and diastolic velocities, as well as Pulsatility Index (PI) were measured in all the arteries evaluated. We carefully measured the following: Middle Cerebral Artery (MCA), Anterior Cerebral Artery (ACA), Anterior Communicating Artery (AcoA) Posterior Communicating Artery (PcoA), Basilar Artery (BA), Vertebral Arteries (VA) and Posterior Cerebral Arteries (PCA) of both hemispheres.

Clinical findings

LBP patients consisted of 5 women and 7 men, a mean age 74 years and a mean disease onset of 5 years. H-Y scale: 9 patients showed stage II and the remaining 3 showed stages III. S-E scale showed a mean of 70% and a mean L-dopa dose of 845 mg. PD patients consisted of 6 women and 9 men, a mean age 70 years with a mean disease onset of 6 years. H-Y scale: 10 patients showed a stage II and 5 showed a stage III. S-E scale showed a mean of 80% and a mean L-dopa dose of 650mg. High blood pressure was present in all LBP patients (100%, p:0.02) with only 20% of PD patients and 30% of normal subjects exhibiting high blood pressure. Diabetis Mellitus was also present in 50% of LBP patients (p: 0.04) and only 20% of PD patients (Table 1).